由于外部压缩而导致的左心室辅助器件外流移植阻塞的外科手术
Lu Wang1, Muhammad Rafiq1, Katharine Tweed1
1Department of Transplantation and MCS, Royal Papworth Hospital, Cambridge, United Kingdom.
Multimedia manual of cardiothoracic surgery : MMCTS
|October 12, 2023
概括
左心室辅助装置外流移植阻塞,虽然很少见,但很严重. 通过subxiphoid方法去除生物碎片成功地治疗了这种HeartMate 3并发症,防止了进一步的心脏移植的需要.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 手术创新 在外科创新.
背景情况:
- 左心室辅助装置 (LVAD) 外流移植阻塞是一种罕见但严重的并发症.
- 常见的原因包括血栓,扭曲,扭曲和外部压缩.
- 在HeartMate 3设备中生物碎片的积累是外部压缩的新兴原因.
研究的目的:
- 报告一个LVAD外流移植压缩的情况.
- 为了突出显示生物垃圾是HeartMate 3设备压缩的原因.
- 提出一个成功的最小侵入性治疗策略.
主要方法:
- 一个用HeartMate 3 LVAD.患者的案例研究.
- 诊断由于生物碎片而导致的外流移植压缩.
- 通过手术去除生物碎片的治疗,使用subxiphoid方法.
主要成果:
- 成功地清除了生物垃圾.
- 减轻LVAD外流移植压缩的情况.
- 避免设备更换或紧急心脏移植.
结论:
- 生物碎片的积累是LVAD外流移植中外部压缩的重要原因.
- 亚体方法是治疗这种并发症的有效的最小侵入性选择.
- 这种方法可以帮助维护LVAD功能,避免更激烈的干预措施.
相关概念视频
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24


